Home › NDC Lookup › RxCUI directory › RxCUI 315213

Sodium fluoride 2.2 MG Chewable Tablet — RxCUI 315213

Name: Sodium fluoride 2.2 MG Chewable Tablet (RxCUI 315213)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 315213 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI315213

Official nameSodium fluoride 2.2 MG Chewable Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known assodium fluoride 2.2 MG (fluoride ion 1 MG) Chewable Tablet; sodium fluoride 2.21 MG (fluoride ion 1 MG) Chewable Tablet

FDA products mapped9

Package NDCs mapped10

Reported Medicaid activity (SDUD)78,889 prescriptions · 34 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Sodium fluoride 2.2 MG Chewable Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Sodium fluoride 2.2 MG Chewable Tablet RxCUI 315213 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Sodium fluoride 9873 IN
Brand names 5

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Epiflur 894943 BN
- Fluorabon 217162 BN
- Fluoritab 861718 BN
- Ludent 901277 BN
- Nafrinse 352784 BN
Dose forms 28

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Sodium fluoride Chewable Tablet 373907 SCDF
- Sodium fluoride Chewable Product 1295174 SCDG
- Sodium fluoride Oral Product 1159341 SCDG
- Sodium fluoride Pill 1159343 SCDG
- Sodium fluoride Chewable Tablet [Epiflur] 894945 SBDF
- Sodium fluoride Chewable Tablet [Fluorabon] 369768 SBDF
- Sodium fluoride Chewable Tablet [Fluoritab] 861723 SBDF
- Sodium fluoride Chewable Tablet [Ludent] 901279 SBDF
- +20 more in this family
Clinical & branded drugs 11

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Sodium fluoride 2.2 MG 330232 SCDC
- Sodium fluoride 2.2 MG Chewable Tablet [Epiflur] 999494 SBD
- Sodium fluoride 2.2 MG Chewable Tablet [Fluorabon] 540263 SBD
- Sodium fluoride 2.2 MG Chewable Tablet [Fluoritab] 861728 SBD
- Sodium fluoride 2.2 MG Chewable Tablet [Ludent] 901296 SBD
- Sodium fluoride 2.2 MG Chewable Tablet [Nafrinse] 1302475 SBD
- Sodium fluoride 2.2 MG [Epiflur] 999493 SBDC
- Sodium fluoride 2.2 MG [Fluorabon] 1994533 SBDC
- +3 more in this family

Showing up to 8 concepts per family — 22 of 45 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Sodium fluoride 2.2 MG SCDC · 330232
Sodium fluoride Chewable Tablet SCDF · 373907
Sodium fluoride Chewable Product SCDG · 1295174
Sodium fluoride Oral Product SCDG · 1159341
Sodium fluoride Pill SCDG · 1159343

Brand-Name Concepts

Sodium fluoride 2.2 MG Chewable Tablet [Epiflur] SBD · 999494
Sodium fluoride 2.2 MG Chewable Tablet [Fluorabon] SBD · 540263
Sodium fluoride 2.2 MG Chewable Tablet [Fluoritab] SBD · 861728
Sodium fluoride 2.2 MG Chewable Tablet [Ludent] SBD · 901296
Sodium fluoride 2.2 MG Chewable Tablet [Nafrinse] SBD · 1302475
Sodium fluoride 2.2 MG [Epiflur] SBDC · 999493
Sodium fluoride 2.2 MG [Fluorabon] SBDC · 1994533
Sodium fluoride 2.2 MG [Fluoritab] SBDC · 861727
Sodium fluoride 2.2 MG [Ludent] SBDC · 901295
Sodium fluoride 2.2 MG [Nafrinse] SBDC · 1302474

📦 FDA Products & Package NDCs

9 products · 10 package NDCs

10 package NDCs map to RxCUI 315213 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
58657-0160-12	120 TABLET in 1 BOTTLE (58657-160-12)	Sodium Fluoride Chewable	Method Pharmaceuticals, LLC	2018-08-17
58657-0161-10	1000 TABLET in 1 BOTTLE (58657-161-10)	Sodium Fluoride Chewable	Method Pharmaceuticals, LLC	2018-08-17
58657-0161-12	120 TABLET in 1 BOTTLE (58657-161-12)	Sodium Fluoride Chewable	Method Pharmaceuticals, LLC	2018-08-17
58657-0162-12	120 TABLET in 1 BOTTLE (58657-162-12)	Sodium Fluoride Chewable	Method Pharmaceuticals, LLC	2018-08-17
63629-1133-01	120 TABLET in 1 BOTTLE (63629-1133-1)	Sodium Fluoride Chewable	Bryant Ranch Prepack	2020-10-06
71335-2724-01	120 TABLET in 1 BOTTLE (71335-2724-1)	Sodium Fluoride Chewable	Bryant Ranch Prepack	2025-07-29
72162-1654-02	120 TABLET in 1 BOTTLE (72162-1654-2)	Sodium Fluoride Chewable	Bryant Ranch Prepack	2024-04-04
75826-0163-20	120 TABLET, CHEWABLE in 1 BOTTLE (75826-163-20)	Fluoride	WINDER LABORATORIES, LLC	2024-01-01
75826-0164-20	120 TABLET, CHEWABLE in 1 BOTTLE (75826-164-20)	Fluoride	WINDER LABORATORIES, LLC	2024-01-01
75826-0165-20	120 TABLET, CHEWABLE in 1 BOTTLE (75826-165-20)	Fluoride	WINDER LABORATORIES, LLC	2024-01-01

Observed labelers: Method Pharmaceuticals, LLC (4) · Bryant Ranch Prepack (3) · WINDER LABORATORIES, LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.